이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Evaluation of the Effect of Virtual Reality Application on Postoperative Pain and Anxiety in Women (Pain)

2026년 11월 15일 업데이트: Songul Gungor, Osmaniye Korkut Ata University

Effects of a Nature-Based Virtual Reality Intervention on Postoperative Pain and Anxiety in Women Undergoing Total Knee Arthroplasty or Cesarean Delivery: A Randomized Controlled Study

Surgical interventions, while significant milestones in patients' physical recovery processes, can be a major source of concern for patients due to postoperative pain, which is also an important component of postoperative care. If postoperative pain is not managed properly, it can lead to increased levels of anxiety and fear, as well as deterioration in overall comfort and quality of life. The ineffective management of postoperative pain has economic and medical consequences such as patient dissatisfaction, delayed hospital discharge, increased rates of hospital readmission, and dissatisfaction with medical care. Therefore, effective management of postoperative pain is of great importance for patient well-being. Factors associated with postoperative pain have been reported in many studies. For example, being female and the type of surgery. Therefore, considering gender and type of surgery in the management of postoperative pain is crucial to optimize the recovery process for patients. In recent years, research on the use of innovative technologies such as virtual reality in the management of postoperative pain has increased. Virtual reality can reduce postoperative pain by creating a sense of being in a different environment for patients and diverting their attention away from pain.

연구 개요

상태

완전한

상세 설명

This randomized controlled trial evaluated the effects of virtual reality (VR) on postoperative pain, anxiety, physiological parameters, and analgesic use in women aged 18 years and older undergoing total knee arthroplasty (TKA) or cesarean section (CS) at Osmaniye State Hospital. The study also examined whether the effects of VR differed by surgery type.

Within each surgery category, eligible participants were assigned to VR or control groups using a lottery method performed by clinical nurses who were not members of the research team. Folded slips indicating VR or control allocation were drawn from a box, resulting in four groups: VR-TKA, control-TKA, VR-CS, and control-CS. Participants, the intervention provider, and the outcome assessor were aware of group allocation.

Baseline assessments (T1) were performed at postoperative hour 24, 40 minutes after analgesic administration. Pain and anxiety were assessed using separate 10-cm Visual Analog Scales (VAS). Physiological measurements included systolic and diastolic blood pressure, pulse rate, and peripheral oxygen saturation (SpO₂).

Participants in the VR groups received a 10-minute VR session in addition to routine postoperative care. They selected one of four relaxing nature videos featuring lake and river scenery, the sea and a tropical beach, morning nature scenes, or forest scenery. The device and planned intervention duration were standardized, while content selection reflected individual preferences. Videos were presented without headphones at the device's maximum volume. Control groups received routine postoperative care without VR. All assessments were repeated immediately after the 10-minute intervention or corresponding control period (T2). VR sessions and assessments were conducted with participants in a semi-sitting position in bed.

Analgesic use was obtained from patient records and medication administration charts. Video preferences, intervention completion, and participants' feedback regarding their VR experience were recorded. When participants reported dizziness, the video was stopped. Sixteen participants discontinued VR because of dizziness; the final analyses included 126 participants who completed the study: 36 in VR-TKA and 30 in each of the other three groups.Analgesic use was obtained from patient records and medication administration charts. Video preferences, intervention completion, participants' feedback regarding their VR experience, and the occurrence of dizziness during the VR session were recorded. When participants reported dizziness, the video was stopped, and their T2 assessments were performed at the time the headset was removed. Sixteen participants discontinued VR because of dizziness.

The primary analysis included all 142 randomized participants in the groups to which they were assigned (intention-to-treat), using analysis of covariance (ANCOVA) with the T2 score as the dependent variable, the T1 score as the covariate, and VR status and surgery type as fixed factors, including their interaction. Two sensitivity analyses were performed: a conservative analysis in which the T1 scores of participants who discontinued VR were carried forward as their T2 scores (n = 142), and a per-protocol analysis including only participants who completed the intervention (n = 126: 36 in VR-TKA and 30 in each of the other three groups). The primary models were also repeated with age as an additional covariate.

The study was initially approved by the Osmaniye Korkut Ata University Ethics Committee on November 29, 2023 (Decision No. 2023/8/3), and institutional permission was obtained from Osmaniye State Hospital on December 22, 2023. However, after the gynecologic surgeons left the hospital, hysterectomy procedures were no longer performed, and eligible hysterectomy patients could not be recruited. Therefore, the hysterectomy group was replaced with a cesarean section group, and a protocol amendment was approved by the ethics committee on March 2, 2026 (Decision No. 2026/3/2). Recruitment of cesarean section participants began after this amendment was approved.Data for the total knee arthroplasty groups were collected between January 2024 and December 2024 under the initial ethics approval. Data for the cesarean section groups were collected between March 2026 and November 2026, after the protocol amendment had been approved. Ethical approval was obtained from the Osmaniye Korkut Ata University Ethics Committee (Decision No. 2023/8/3, November 29, 2023), and institutional permission was obtained from Osmaniye State Hospital (December 22, 2023). A protocol amendment replacing the hysterectomy group with a cesarean section group was approved on March 2, 2026 (Decision No. 2026/3/2). Written informed consent was obtained from all participants, and the study was conducted in accordance with the Declaration of Helsinki.

연구 유형

중재적

등록 (실제)

76

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Osmani̇ye
      • Center, Osmani̇ye, 터키 (Türkiye), 80010
        • Osmaniye Korkut Ata University
      • Center, Osmani̇ye, 터키 (Türkiye), 80010
        • Osmaniye State Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

여성

설명

Inclusion Criteria:

  • Being female and aged 18 years or older.
  • Having undergone total knee arthroplasty or cesarean section.
  • Being at postoperative hour 24.
  • Being conscious and able to communicate.
  • Being able to understand the assessment instruments.
  • Having no severe visual or hearing impairment or physical condition that would prevent the use of a VR headset.

Exclusion Criteria:

  • Having severe cognitive or communication difficulties.
  • Experiencing deterioration in clinical condition.
  • Having a neurological or vestibular disorder.
  • Experiencing active nausea or vomiting.
  • Having an active eye infection.
  • Having wounds in the facial or head region that would interfere with VR headset use.

Withdrawal Criterion:

- Requesting withdrawal from the study.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 지지 요법
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 더블

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Total Knee Replacement VR Intervention Group

Participants who underwent total knee arthroplasty completed baseline assessments (T1) of pain and anxiety using separate 10-cm Visual Analog Scales (VAS), along with measurements of systolic and diastolic blood pressure, pulse rate, and SpO₂. They then received a 10-minute VR intervention in addition to routine postoperative care. All assessments were repeated immediately after the intervention (T2).

Participants undergoing VR intervention will experience a VR program of their choice based on personal preferences. Among these programs are videos offering natural visual experiences. For instance, participants can opt for videos featuring seaside views, forest tours, or lake landscapes.

간섭 없음: Total Knee Replacement Control Group

Participants who underwent total knee arthroplasty completed baseline assessments (T1) of pain and anxiety using separate 10-cm Visual Analog Scales (VAS), along with measurements of systolic and diastolic blood pressure, pulse rate, and SpO₂. They received routine postoperative care without VR. All assessments were repeated after the same 10-minute interval used in the VR group (T2).

실험적: Cesarean Section VR Intervention Group

Pre-Test + Intervention + Post-Test) Participants who underwent cesarean section surgery and received a pre-test, followed by VR intervention.Participants in this group are initially assessed with a pre-test, followed by VR intervention.

Participants undergoing VR intervention will experience a VR program of their choice based on personal preferences. Among these programs are videos offering natural visual experiences. For instance, participants can opt for videos featuring seaside views, forest tours, or lake landscapes.

간섭 없음: Total Knee Group

Participants who underwent total knee arthroplasty completed baseline assessments (T1) of pain and anxiety using separate 10-cm Visual Analog Scales (VAS), along with measurements of systolic and diastolic blood pressure, pulse rate, and SpO₂. They received routine postoperative care without VR. All assessments were repeated after the same 10-minute interval used in the VR group (T2).

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
The VR application is effective in changing postoperative pain.
기간: The researcher's first visit to the patient on postoperative day 1.

Pain intensity was assessed using a 10-cm Visual Analog Scale (VAS) in women aged 18 years and older undergoing total knee arthroplasty or cesarean section. Baseline assessments (T1) were performed at postoperative hour 24, 40 minutes after analgesic administration. Participants in the VR groups then received a 10-minute VR intervention alongside routine care, while control groups continued to receive routine care alone. Pain intensity was reassessed (T2) immediately after this 10-minute period in all groups.

The researcher's first visit to the patient on postoperative day 1.

2차 결과 측정

결과 측정
측정값 설명
기간
The VR application is effective in changing postoperative anxiety.
기간: The researcher's first visit to the patient on postoperative day 1.

Pain intensity was assessed using a 10-cm Visual Analog Scale (VAS) in women aged 18 years and older undergoing total knee arthroplasty or cesarean section. Baseline assessments (T1) were performed at postoperative hour 24, 40 minutes after analgesic administration. Participants in the VR groups then received a 10-minute VR intervention alongside routine care, while control groups continued to receive routine care alone. Pain intensity was reassessed (T2) immediately after this 10-minute period in all groups.

The researcher's first visit to the patient on postoperative day 1.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Songül GÜNGÖR, Phd, Osmaniye Korkut Ata University
  • 연구 책임자: Ayşe TAŞTEKİN, associate professor, Afyonkarahisar Health Sciences University

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 4월 15일

기본 완료 (실제)

2026년 11월 1일

연구 완료 (실제)

2026년 11월 1일

연구 등록 날짜

최초 제출

2024년 3월 2일

QC 기준을 충족하는 최초 제출

2024년 5월 28일

처음 게시됨 (실제)

2024년 5월 30일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 18일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 15일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다